Has Anthony Romeo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $26,845,427 in general payments to Anthony Romeo, MD across 621 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anthony Romeo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anthony Romeo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anthony Romeo, MD

Orthopaedic Surgery · New York, NYNPI 1013996891

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $25,561,082 of the $26,845,427 with a category attached, or 95.2%. Arthrex accounts for 98.5% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $5,380,954, 2.3 times the $2,376,030 reported in 2019. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,845,427in general payments, 2019–2025

Across 621 payments — averaging $43,229 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$26.5M
Johnson & Johnson$388K
Medwest Associates$477
Alpha Orthopedic Systems$213
Exactech, Inc.$191
Left Coast Surgical Inc$173
plus $894 from 10 others

$108,109in research payments, 2019–2025

Across 4 payments — averaging $27,027 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Vertex$108K

What the payments were for

Royalty or licence$25,561,08295%
Consulting fees$228,1611%
Speaking & faculty fees$639,7152%
Travel & lodging$20,9650%
Food & beverage$8,2220%
Other$387,2831%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	592	$26,455,935
Johnson & Johnson	3	$387,544
Medwest Associates	9	$477
Alpha Orthopedic Systems	2	$213
Exactech, Inc.	1	$191
Left Coast Surgical Inc	1	$173
Pacira Therapeutics, Inc.	2	$160
Acumed LLC	1	$149
Gotham Surgical Solutions & Devices, Inc.	1	$144
Legacy Ortho LLC	1	$115
Stryker	2	$98
Heron Therapeutics, Inc.	2	$96
DJO, LLC	1	$49
Medtronic	1	$31
Zimmer Biomet	1	$30
Vericel Corporation	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$88,562,076
AR-9301-02$10,836,104
ARTHROPLASTY IMPLANTS SHOULDER ARTHROPLASTY & FRACTURE UNIVERS$3,495,843
ARTHROPLASTY IMPLANTS SHOULDER ARTHROPLASTY & FRACTURE REVERS$3,486,073
SHOULDER IMPLANTS BICEPS REPAIR SWIVELOCK TENODESIS$3,486,073
SHOULDER IMPLANTS OTHER PEC REPAIR$3,486,073
SHOULDER IMPLANTS BICEPS REPAIR BUTTON FIXATION$3,486,073
ARTHROPLASTY IMPLANTS REVERS TOTAL SHOULDER REVERS$1,247,547
ARTHROPLASTY IMPLANTS REVERS TOTAL SHOULDER UNIVERSAL GLENOID$1,247,438
ARTHROPLASTY IMPLANTS ANATOMIC TOTAL SHOULDER UNIVERS$1,247,438
ARTHROPLASTY IMPLANTS REVERS TOTAL SHOULDER MODULAR GLENOID SYSTEM$1,247,438
ARTHROPLASTY IMPLANTS ANATOMIC TOTAL SHOULDER ECLIPSE$1,247,438
ARTHROPLASTY INSTRUMENTS SHOULDER ARTHROPLASTY & FRACTURE VIP TECHNOLOGY$8,020
EQUINOXE$191
Clavicle Plating System$149
INHANCE$146
ATTUNE$115

How this compares

$26,845,427 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$47,374

Medicare patients

111

Services billed

649

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in New York

Lawrence LenkeNew York$26.8M
Edwin SuNew York$13.2M
William RicciNew York$11.6M
Steven HaasNew York$11.3M
Giles ScuderiNew York$10.7M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M
Geoffrey WestrichNew York$7.1M
Andrew PearleNew York$6.7M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →